Evidence map›Paper›PMID 41727627›Full record

ArticleResearch square2026

A host anti-amyloidogenic stomach-specific protein inhibits colonization and biofilm formation by adherent invasive Escherichia coli in the colon.

Arpitha Mysore Rajashekara, Theodore Reed, Alvaro Torres-Huerta, Mark Gomulinski, Antonia Boger-May, Morgan Hiller, Emily Cronberger, Grace Kane, Alexa Fowler, Kailyn Jessel and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arpitha Mysore RajashekaraUniversity of Notre Dame.
Theodore ReedUniversity of Notre Dame.
Alvaro Torres-HuertaIndiana University - Purdue University Indianapolis.
Mark GomulinskiUniversity of Michigan-Ann Arbor.
Antonia Boger-MayIndiana University - Purdue University Indianapolis.
Morgan HillerUniversity of Notre Dame.
Emily CronbergerUniversity of Notre Dame.
Grace KaneUniversity of Notre Dame.
Alexa FowlerUniversity of Notre Dame.
Kailyn JesselUniversity of Michigan-Ann Arbor.
Matthew ChapmanUniversity of Michigan-Ann Arbor.
David BooneIndiana University - Purdue University Indianapolis.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrokine-1 (Gkn1) is an anti-amyloidogenic host protein secreted into the gut lumen by the stomach. Gut bacteria make functional amyloids to facilitate biofilm formation and biofilms in the gastrointestinal tract are associated with a variety of disorders, including inflammatory bowel disease. Adherent invasive Escherichia coli (AIEC) is a pathobiont that produces amyloids, forms biofilms, and is associated with inflammatory bowel disease. We therefore investigated whether Gkn1 is required to clear AIEC from the gastrointestinal tract by comparing the course of infection in wild-type and Gkn1-deficient (Gkn1

Identifiers

PMID41727627
PMCPMC12919244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.